Evaluating clinician led and patient empowered CGM SOLUTIONS : customizing based on patient needs

Speciality: All Speciality


Speaker:

Dr. Jothydev Kesavadev | Chairman and Managing Director Jothydevs Diabetes Research Center, Trivandrum

Description:

A warm welcome to all the medical professionals in this interesting session on Assessing CGM solutions: blend clinician guidance with patient autonomy for tailored diabetes care.

Evaluating CGM solutions involves balancing clinician-led oversight with patient empowerment, ensuring customization based on individual needs. Clinician-led approaches provide expert guidance, structured care, and standardized protocols, offering a foundation of support and expertise. Conversely, patient empowerment emphasizes autonomy and self-management, enabling individuals to make real-time decisions and adapt their treatment according to lifestyle and preferences.

Customization involves tailoring education, alert settings, and treatment plans to meet diverse patient needs. By integrating both approaches, healthcare providers can offer personalized care that combines clinical expertise with patient preferences and lifestyle factors. This collaborative approach fosters a sense of ownership and responsibility for managing diabetes while benefiting from professional guidance and support.

Ultimately, evaluating CGM solutions should consider how well they balance clinician-led guidance with patient empowerment, ensuring that each individual receives personalized care that optimizes their diabetes management journey.

Therefore, get an overall knowledge on Assessing CGM solutions: blend clinician guidance with patient autonomy for tailored diabetes care. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessi

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In leukemia, allogeneic HCT is beneficial following primary induction failure.

2.

Team finds broken 'brake' on cancer mutation machine.

3.

Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer

4.

Prostate cancer screening program beneficial in top decile of polygenic risk score

5.

Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot